生物制剂市场战略、顶尖企业、增长机会、2031 年分析及预测

  • Report Code : TIPRE00002765
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 200
Buy Now

Biologics Market Report, Analysis, Opportunities by 2031

Buy Now

生物制剂市场规模预计将从 2023 年的 4692 亿美元增至 2031 年的 17939 亿美元。预计 2023-2031 年市场复合年增长率将达到 18.2%。研发 (R&D) 活动的增加和对生物制剂的投资增加可能会成为生物制剂市场的主要趋势。

生物制剂市场分析

慢性病病例和诊断数量的增加引发了对复杂诊断和治疗药物的需求,这对全球生物制剂市场做出了重大贡献。涉及新化合物的发现研究旨在探索对常规治疗没有反应并显示出更强的保护性和有效性的患者的治疗选择。生物制剂是转基因药物,针对由免疫系统对有害刺激作出反应而引发的炎症的特定部位。鉴于COVID-19的出现,各国政府也采取措施促进医疗保健行业并确保生物制剂供应。此外,研究人员和科学家正在研究各种物种和表达系统,以提高生物制剂的生产率。开发细胞系和试剂以提高生物制剂制造工艺的产量将进一步有利于生物制剂市场的增长。然而,严格的法规和高昂的药物开发成本限制了市场的增长。

生物制剂市场概况

生物制剂正在成为制药行业一个充满活力且前景光明的治疗领域,为治疗各种疾病和医疗状况提供了独特的方法。由于制药和生物技术公司在改善生产设施方面投入巨资,生物制剂市场不断增长。老年人口患癌症和自身免疫性疾病等慢性疾病的风险很高,这反映出对生物制剂和药物的治疗需求。单克隆抗体 (MAbs)、疫苗、重组蛋白、反义、RNAi 和分子疗法等生物制剂正在被研究用于治疗这些医疗状况的潜力。MAbs 在治疗应用中越来越受欢迎,因为它们具有针对特定抗原的特异性和有效性。因此,对治疗的不断增长的需求和对外包的偏好为生物制剂市场的增长提供了动力。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

生物制剂市场:

生物制剂市场
  • Biologics Market
    复合年增长率(2023 - 2031)
    18.2%
  • 2023 年市场规模
    4,692 亿美元
  • 市场规模 2031年
    17,939亿美元

市场动态

增长动力
  • 慢性病患病率不断上升
未来趋势
  • 企业的战略举措
机会
  • 发展中地区生物技术的发展

关键人物

  • 艾伯维公司(AbbVie Inc.)
  • 辉瑞公司
  • 三星生物制剂
  • ADMA Biologics 公司
  • 药明生物
  • 康泰伦特公司
  • AGC 生物制剂
  • 阿斯利康
  • 安进公司
  • Avecia Biologics

区域概况

Biologics Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Biologics Market产品
  • 单克隆抗体
  • 疫苗
  • 重组激素/蛋白质
  • 细胞和基因治疗
Biologics Market应用
  • 癌症
  • 传染病
  • 自身免疫性疾病
Biologics Market来源
  • 哺乳类
  • 微生物
Biologics Market制造业
  • 外包
  • 内部
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

生物制剂市场驱动因素和机遇

慢性病患病率上升利好生物制剂市场

根据Ellerston Capital Limited发表的一项研究《慢性病:生物学方法》,全球每年有4100万人死于慢性病,占全球死亡人数的74%。2020年癌症导致近1000万人死亡,即每6人中就有1人死于癌症。根据GLOBOCAN的数据,2020年全球登记的癌症病例为1930万例,预计到2030年将上升到2460万例。此外,自身免疫性疾病的患病率每年增加3-9%。预计到2030年,阿尔茨海默病病例将达到7800万例,到2050年将达到1.39亿例。根据世界卫生组织(WHO)的数据,每年全球约有1700万人在70岁之前死于非传染性疾病。

抗体和疫苗等生物制剂可提供更有针对性的治疗,因为它们旨在以特定方式与免疫系统相互作用,从而发挥治疗或预防作用。生物药物具有治疗一些慢性自身免疫性疾病的潜力,它通过阻断免疫系统过度活跃的成分(在许多情况下是蛋白质)来治疗一些慢性自身免疫性疾病,这些成分会损害关节、皮肤和其他身体部位。用生物制剂治疗癌症涉及使用人体的免疫细胞杀死癌细胞;干扰素、白细胞介素和单克隆抗体等细胞因子是治疗癌症最常用的生物疗法。因此,慢性病的日益流行推动了生物制剂市场的增长。

发展中地区生物技术产业的发展为生物制剂市场增长创造机会

从基础研究到创新医学治疗方法,现代生物技术的许多应用都需要抗体。治疗性抗体的开发为治疗各种疾病开辟了新途径,证明了这些粒子的转化能力。抗体在诊断中也至关重要,因为它们提供了准确可靠的疾病识别方法。政府的支持日益增加、公私伙伴关系日益增多、疾病状况不断变化以及资金活动不断增加,正在广泛提高亚太地区、南美洲和中美洲以及中东和非洲等地区生物技术产业的表现。阿联酋、沙特阿拉伯、阿曼、马斯喀特、巴林、台湾、马来西亚、印度、中国、新加坡和日本等国家是生物技术行业最有利可图的市场。生物技术、遗传学和细胞生物学的进步有助于确定几种潜在的靶向治疗疗法。生物技术是中国的战略行业。中国制造 2025 计划强调支持高科技产品(包括创新药物)制造的研究能力。该计划旨在让中国制药公司瞄准目标领域,以促进生物技术创新并提高出口。亚洲国家更注重利用基因组学、蛋白质组学和生物标志物进步进行诊断和治疗应用。因此,发展中地区生物技术行业的持续发展预计将在未来几年为生物制剂市场创造机会。

生物制剂市场报告细分分析

有助于生物制剂市场分析的关键部分是产品、应用、来源和制造。

  • 基于产品方面,生物制剂市场分为单克隆抗体、疫苗、重组激素/蛋白质、细胞和基因治疗等。单克隆抗体领域在 2023 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。
  • 根据应用,市场分为癌症、传染病、自身免疫性疾病等。癌症领域在 2023 年占据了最大的市场份额;预计在 2023-2031 年期间将实现最高的复合年增长率。
  • 根据来源,生物制剂市场分为哺乳动物和微生物。微生物领域在 2023 年占据了更大的市场份额。预计哺乳动物领域在预测期内的复合年增长率会更高。
  • 在制造方面,市场分为外包和内部制造。外包部分在 2023 年占据了更大的市场份额,预计在 2023-2031 年期间将实现更高的复合年增长率。

生物制剂市场份额按地区分析

生物制剂市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲。

北美主导着生物制剂市场。该地区的市场增长归因于慢性病的高发病率、众多领先的生物制药公司、优惠的报销政策以及对研发的大量投资。根据 JAMA Network 发表的一篇文章,生物制剂研发支出占美国药物研发总支出的 37%。该国生物制剂处方数量和针对性药物开发的投资正在增加。此外,反义、基因治疗和 RNAi 疗法等几种新型生物药物的批准预计将进一步推动市场增长。预计亚太地区将在 2023-2031 年期间录得最高复合年增长率。

生物制剂市场报告范围

报告属性细节
2023 年的市场规模4692亿美元
2031 年市场规模17939亿美元
全球复合年增长率(2023 - 2031)18.2%
史料2021-2022
预测期2024-2031
涵盖的领域按产品
  • 单克隆抗体
  • 疫苗
  • 重组激素/蛋白质
  • 细胞和基因治疗
按应用
  • 癌症
  • 传染病
  • 自身免疫性疾病
按来源
  • 哺乳类
  • 微生物
按制造业
  • 外包
  • 内部
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 艾伯维公司(AbbVie Inc.)
  • 辉瑞公司
  • 三星生物制剂
  • ADMA Biologics 公司
  • 药明生物
  • 康泰伦特公司
  • AGC 生物制剂
  • 阿斯利康
  • 安进公司
  • Avecia Biologics
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

生物制剂市场新闻和最新发展

生物制剂市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了市场的一些发展情况:

  • 全球合同开发和制造组织 (CDMO) Samsung Biologics 宣布与 LegoChem Biosciences 达成合作协议,LegoChem Biosciences 是一家开创抗体药物偶联物 (ADC) 项目研发的生物技术公司。根据协议条款,Samsung Biologics 将提供抗体开发和药物物质制造服务,作为 LegoChem Biosciences 旨在治疗实体肿瘤的 ADC 项目的一部分。(Samsung Biologics,新闻稿,2024 年 2 月)
  • Selvita SA 宣布了一项战略计划,旨在大幅扩展其服务组合,并通过在其产品组合中增加全面的治疗性抗体发现和开发能力,进入生物药物发现和开发领域。(Selvita,新闻稿,2024 年 3 月)

生物制剂市场报告覆盖范围和交付成果

“生物制剂市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 生物制剂市场规模及全球、区域和国家层面所有关键细分市场的预测
  • 生物制剂市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 生物制剂市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及生物制剂市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the biologics market?

The market is expected to register a CAGR of 18.2% during 2023–2031.

What would be the estimated value of the biologics market by 2031?

The estimated value of the market would be US$ 1,793.9 billion by 2031.

What are the future trends in the biologics market?

Strategic initiatives by companies would bring attractive trends in the market in the coming years.

Which are the leading players operating in the biologics market?

AbbVie Inc., Pfizer Inc., Samsung Biologics, ADMA Biologics Inc., WuXi Biologics, Catalent Inc, AGC Biologics, Crescendo Biologics Limited, Zumutor Biologics INC, Theriva Biologics, AstraZeneca, Amgen Inc., Avecia Biologics, and Quality Assistance s.a. are among the key players in the market.

Which region dominated the biologics market in 2023?

North America dominated the market in 2023.

What are the driving factors impacting the biologics market?

The increasing prevalence of chronic diseases and preference for outsourcing manufacturing operations are among the pivotal factors fueling the market growth.

The List of Companies - Biologics Market

  1. AbbVie Inc.
  2. Pfizer Inc.
  3. Samsung Biologics
  4. ADMA Biologics, Inc.
  5. WuXi Biologics
  6. Catalent, Inc
  7. AGC Biologics
  8. AstraZeneca
  9. Amgen Inc.
  10. Avecia Biologics
  11. Quality Assistance s.a.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..